What I have: a TFA mobile phase · orforglipron · a C4 column. I can predict the outcome but I cannot explain it, which means I will get the next case wrong. I would…
All questions
Newest first. 5.2k questions across 107 tags.
Numbers first: SURPASS-2 · retatrutide. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone else’s…
The trend is what I care about; individual weeks are obviously noise. This is a planning question. I know what my options are; I do not know how to weigh them. What I…
Details up front: SWB · QSC · Germany. I want to know what the trade-off actually is rather than which option is fashionable. I would rather have a defensible reason…
What I have: 2 mg · 10 mg/mL. This should be a straightforward calculation and I keep getting two different answers. The numbers are arbitrary; the method is what I…
Details up front: TSH · magnesium · liraglutide. I want to know what the trade-off actually is rather than which option is fashionable. I would rather have a…
Concretely: 96.8% · VendorInvestigate · 98.2% · Medutest. I would like the axes of comparison first and the recommendation second. I have tried the first option and…
Conditions: constipation · ten · dulaglutide. I have done this once and I suspect I got away with it rather than got it right. For context: I keep records of every…
The case in front of me: SURMOUNT-2 · fatigue. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a single…
The case in front of me: survodutide · SURMOUNT-4. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a…
Concretely: TFC · Tianjin · Poland. The failure mode I am trying to avoid is making this decision emotionally. I have twelve months in view and I would like the plan…
Two things I have been told confidently and suspect are both wrong. First, that suppliers ask for crypto "because it is untraceable". That cannot be right for a…
The case in front of me: ecnoglutide · minus 20 °C · twenty-one days. The failure mode I am trying to avoid is making this decision emotionally. I have twelve months…
Concretely: Xianning · Germany. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a single result, which I…
The particulars: tirzepatide · 1 mg/mL. I would like to define my thresholds before I have a result, for obvious reasons. I want a plan with explicit stopping rules,…
The material is still sealed, so I have not committed to anything yet. I want a method I can write down and repeat, not a rule of thumb. I would rather over-engineer…
For reference: peptide mapping · ecnoglutide. I would like to define my thresholds before I have a result, for obvious reasons. I want a plan with explicit stopping…
For reference: PeptideMeter · Tianjin Finder Chemical. I want to understand what this actually establishes, as opposed to what it is being used to imply. My concern…
The particulars: deamidation · ecnoglutide · 4 °C. I would like the mechanism, because I want to be able to reason about the cases nobody has written about. I have…
The particulars: 5 mg/mL · survodutide. The comparison I want does not seem to exist anywhere in a form I can evaluate. I have read the arguments for each and they do…
What I am working with: dulaglutide · room temperature · ten days. I would like to set this up properly once, rather than adjust it repeatedly. My budget is real but…
For context, I am working with a 10 mg presentation and a 2 mL fill. This is a procedural question rather than a theoretical one, and I would like the procedure…
Setup, so nobody has to ask: orforglipron · 37 °C. This is a procedural question rather than a theoretical one, and I would like the procedure rather than the theory.…
Details up front: Changsha · Poland. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to disagree,…